20 years of investor engagement
We’re celebrating two decades of investor engagement. The decade ahead is vital for securing a sustainable future – join us on the journey.
Share
Responsible investment runs deep
At BMO we invest with a purpose – to boldly grow the good. It is an ethos we are proud of and one that is engrained in our heritage, from the launch of Europe’s first ethically screened fund in 1984. Today, all our active investment teams integrate ESG considerations into their decision making and we continue to develop dedicated and high-quality responsible funds and solutions. Through our commitment to responsible investing, we believe we are putting our purpose into action, and playing our part in the wider investor movement making finance a force for good.
Risk disclaimer
All of our investment plans involve a level of risk and the value of your investments can go down as well as up. The level of risk will depend upon the underlying investments that you choose to hold in the plans. You need to be comfortable that you may not get back the original amount invested.
20 years of engagement
companies engaged
Countries
instances of positive change recorded in ESG practices
As at 31 Dec 2019
Discover the history of investor engagement
Early investor engagement was a relatively niche activity, largely driven by mission and faith-based investors. A significant obstacle to scaling up these efforts was a lack of common definitions and standards for sustainability. This changed in the late 1980s, with the United Nations founding some of the key institutions and concepts that have guided action on sustainability ever since. With these building blocks in place, the stage was set for the sustainability agenda to enter the mainstream. Discover the journey below:
Discover our global influence
Hover over the locations below to discover the instances of positive change – ‘milestones’ – we have achieved through engagement over the past 20 years.
- Enviromental
- Social
- Governance
Investor engagement in action
Our engagement insights
ESG Viewpoint – COVID-19 and the pharmaceutical industry
ESG Viewpoint – Racial justice: the imperative for investor action
